Heterocyclic methyl sulfone derivative
Details for Australian Patent Application No. 2004251987 (hide)
International Classifications
Event Publications
5 January 2006 PCT application entered the National Phase
PCT publication WO2005/000798 Priority application(s): WO2005/000798
1 July 2010 Application Accepted
Published as AU-B-2004251987
22 July 2010 Corrigenda
Applications Accepted - Name Index Under the name Daiichi Pharmaceutical Co., Ltd., Application No. 2004251987, under INID (71) correct the applicant name to Daiichi Sankyo Company, Limited
29 July 2010 Application for Amendment
The nature of the amendment is as shown in the statement(s) filed 07 Jul 2010. Address for service in Australia - Phillips Ormonde Fitzpatrick 367 Collins Street Melbourne VIC 3000
18 November 2010 Amendment Made
The nature of the amendment is as shown in the statement(s) filed 07 Jul 2010
25 November 2010 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2004252005-Cannabinoid receptor modulator
2004251984-Unite holder for electrical equipment, for example for a lamp assembly
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser